Boston Scientific CorporationBoston Scientific CorporationBoston Scientific Corporation

Boston Scientific Corporation

No trades

Key facts today


Boston Scientific announced that Yoshiaki Fujimori will not seek re-election at the 2026 Annual Meeting. He has served on the board since July 2016 and chairs the Risk Committee.
Canaccord Genuity has reduced its price target for Boston Scientific shares from $131.00 to $112.00.
Analyze the impactAnalyze the impact
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪115.14 B‬USD
1.96USD
‪2.89 B‬USD
‪20.07 B‬USD
‪1.48 B‬
Beta (1Y)
0.92

About Boston Scientific Corporation


CEO
Michael F. Mahoney
Headquarters
Marlborough
Founded
1979
IPO date
May 19, 1992
Identifiers
3
ISIN US1011371077
Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Check out other big names from the same industry as BSX.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
BSX4800732
Boston Scientific Corporation 3.75% 01-MAR-2026
Yield to maturity
5.95%
Maturity date
Mar 1, 2026
BSX4801034
Boston Scientific Corporation 4.7% 01-MAR-2049
Yield to maturity
5.44%
Maturity date
Mar 1, 2049
BSX.GJ
Boston Scientific Corporation 7.375% 15-JAN-2040
Yield to maturity
5.08%
Maturity date
Jan 15, 2040
BSX4801033
Boston Scientific Corporation 4.55% 01-MAR-2039
Yield to maturity
5.00%
Maturity date
Mar 1, 2039
BSX.GE
Boston Scientific Corporation 6.25% 15-NOV-2035
Yield to maturity
4.67%
Maturity date
Nov 15, 2035
BSX4988126
Boston Scientific Corporation 2.65% 01-JUN-2030
Yield to maturity
4.14%
Maturity date
Jun 1, 2030
BSX4800733
Boston Scientific Corporation 4.0% 01-MAR-2029
Yield to maturity
3.89%
Maturity date
Mar 1, 2029
BSX4602368
Boston Scientific Corporation 4.0% 01-MAR-2028
Yield to maturity
3.78%
Maturity date
Mar 1, 2028
A
XS299338088
American Medical Systems Europe BV 3.25% 08-MAR-2034
Yield to maturity
3.53%
Maturity date
Mar 8, 2034
CH0A
American Medical Systems Europe BV 1.875% 08-MAR-2034
Yield to maturity
3.49%
Maturity date
Mar 8, 2034
A
XS277226669
American Medical Systems Europe BV 3.5% 08-MAR-2032
Yield to maturity
3.25%
Maturity date
Mar 8, 2032

See all BSX bonds 

VTI
Vanguard Total Stock Market ETF
Weight
0.21%
Market value
‪4.44 B‬
USD
VOO
Vanguard S&P 500 ETF
Weight
0.24%
Market value
‪3.58 B‬
USD
VUG
Vanguard Growth ETF
Weight
0.44%
Market value
‪1.54 B‬
USD
IVV
iShares Core S&P 500 ETF
Weight
0.20%
Market value
‪1.48 B‬
USD
SPY
State Street SPDR S&P 500 ETF
Weight
0.20%
Market value
‪1.37 B‬
USD
XLV
State Street Health Care Select Sector SPDR ETF
Weight
2.05%
Market value
‪848.34 M‬
USD
VHT
Vanguard Health Care ETF
Weight
2.06%
Market value
‪426.35 M‬
USD
IHI
iShares U.S. Medical Devices ETF
Weight
9.95%
Market value
‪356.53 M‬
USD
0A3D
iShares Core S&P 500 UCITS ETF
Weight
0.20%
Market value
‪271.24 M‬
USD
GSPX
iShares Core S&P 500 UCITS ETF
Weight
0.20%
Market value
‪271.24 M‬
USD
CSPX
iShares Core S&P 500 UCITS ETF
Weight
0.20%
Market value
‪271.24 M‬
USD

Explore more ETFs 

Frequently Asked Questions


The current price of BSX is 76.27 USD — it has decreased by −1.76% in the past 24 hours. Watch Boston Scientific Corporation stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Boston Scientific Corporation stocks are traded under the ticker BSX.
BSX stock has fallen by −18.03% compared to the previous week, the month change is a −22.40% fall, over the last year Boston Scientific Corporation has showed a −27.86% decrease.
We've gathered analysts' opinions on Boston Scientific Corporation future price: according to them, BSX price has a max estimate of 124.00 USD and a min estimate of 85.00 USD. Watch BSX chart and read a more detailed Boston Scientific Corporation stock forecast: see what analysts think of Boston Scientific Corporation and suggest that you do with its stocks.
BSX reached its all-time high on Sep 9, 2025 with the price of 109.50 USD, and its all-time low was 2.34 USD and was reached on Oct 7, 1993. View more price dynamics on BSX chart.
See other stocks reaching their highest and lowest prices.
BSX stock is 5.40% volatile and has beta coefficient of 0.92. Track Boston Scientific Corporation stock price on the chart and check out the list of the most volatile stocks — is Boston Scientific Corporation there?
Today Boston Scientific Corporation has the market capitalization of ‪115.14 B‬, it has decreased by −0.19% over the last week.
Yes, you can track Boston Scientific Corporation financials in yearly and quarterly reports right on TradingView.
Boston Scientific Corporation is going to release the next earnings report on Apr 29, 2026. Keep track of upcoming events with our Earnings Calendar.
BSX earnings for the last quarter are 0.80 USD per share, whereas the estimation was 0.78 USD resulting in a 2.48% surprise. The estimated earnings for the next quarter are 0.79 USD per share. See more details about Boston Scientific Corporation earnings.
Boston Scientific Corporation revenue for the last quarter amounts to ‪5.29 B‬ USD, despite the estimated figure of ‪5.28 B‬ USD. In the next quarter, revenue is expected to reach ‪5.18 B‬ USD.
BSX net income for the last quarter is ‪668.00 M‬ USD, while the quarter before that showed ‪755.00 M‬ USD of net income which accounts for −11.52% change. Track more Boston Scientific Corporation financial stats to get the full picture.
No, BSX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, BSX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Boston Scientific Corporation stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Boston Scientific Corporation technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Boston Scientific Corporation stock shows the sell signal. See more of Boston Scientific Corporation technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.